467 related articles for article (PubMed ID: 27039996)
1. [The shades of anti-Jo1 positive antisynthetase syndrome in a Hungarian cohort].
Szabó K; Nagy-Vincze M; Bodoki L; Hodosi K; Dankó K; Griger Z
Orv Hetil; 2016 Apr; 157(15):575-83. PubMed ID: 27039996
[TBL] [Abstract][Full Text] [Related]
2. Antisynthetase syndrome with anti-Jo1 antibodies in 48 patients: pulmonary involvement predicts disease-modifying antirheumatic drug use.
Stanciu R; Guiguet M; Musset L; Touitou D; Beigelman C; Rigolet A; Costedoat-Chalumeau N; Allenbach Y; Hervier B; Dubourg O; Maisonobe T; Charuel JL; Behin A; Herson S; Amoura Z; Grenier P; Benveniste O
J Rheumatol; 2012 Sep; 39(9):1835-9. PubMed ID: 22859355
[TBL] [Abstract][Full Text] [Related]
3. Rituximab in the Treatment of Jo1 Antibody-associated Antisynthetase Syndrome: Anti-Ro52 Positivity as a Marker for Severity and Treatment Response.
Bauhammer J; Blank N; Max R; Lorenz HM; Wagner U; Krause D; Fiehn C
J Rheumatol; 2016 Aug; 43(8):1566-74. PubMed ID: 27252419
[TBL] [Abstract][Full Text] [Related]
4. [The antisynthetase syndrome: a subgroup of inflammatory myopathies not to be unrecognized].
Legout L; Fauchais AL; Hachulla E; Queyrel V; Michon-Pasturel U; Lambert M; Hatron PY; Devulder B
Rev Med Interne; 2002 Mar; 23(3):273-82. PubMed ID: 11928375
[TBL] [Abstract][Full Text] [Related]
5. Dermatomyositis sine myositis and antisynthetase syndrome.
Climent-Albaladejo A; Saiz-Cuenca E; Rosique-Roman J; Caballero-Rodriguez J; Galvez-Munoz J
Joint Bone Spine; 2002 Jan; 69(1):72-5. PubMed ID: 11858361
[TBL] [Abstract][Full Text] [Related]
6. [Antisynthetase syndrome: a retrospective study of 14 patients].
Dieval C; Ribeiro E; Mercié P; Blanco P; Duffau P; Longy-Boursier M
Rev Med Interne; 2012 Feb; 33(2):76-9. PubMed ID: 22204922
[TBL] [Abstract][Full Text] [Related]
7. [The anti-Jo-1 syndrome - a specific form of myositis with interstitial lung disease].
Häussermann A; Gillissen A; Seidel W
Pneumologie; 2010 Aug; 64(8):496-503. PubMed ID: 20387195
[TBL] [Abstract][Full Text] [Related]
8. Anti-Jo-1 antibody positive polymyositis--successful therapy with leflunomide.
Lange U; Piegsa M; Müller-Ladner U; Strunk J
Autoimmunity; 2006 May; 39(3):261-4. PubMed ID: 16769661
[TBL] [Abstract][Full Text] [Related]
9. [Antisynthetase syndrome].
Gran JT
Tidsskr Nor Laegeforen; 2002 Sep; 122(23):2270-2. PubMed ID: 12448266
[TBL] [Abstract][Full Text] [Related]
10. Antisynthetase syndrome.
Katzap E; Barilla-LaBarca ML; Marder G
Curr Rheumatol Rep; 2011 Jun; 13(3):175-81. PubMed ID: 21455765
[TBL] [Abstract][Full Text] [Related]
11. [The antisynthetase syndrome: a cause of rapidly progressive interstitial lung disease].
Jordan Greco AS; Métrailler JC; Dayer E
Rev Med Suisse; 2007 Nov; 3(134):2675-6, 2679-81. PubMed ID: 18159702
[TBL] [Abstract][Full Text] [Related]
12. Jo1-antisynthetase syndrome and severe interstitial lung disease with organising pneumonia on histopathology with favourable outcome on early combined treatment with corticosteroids, mycophenolate mofetil and rituximab.
Rüegg CA; Maurer B; Laube I; Scholtze D
BMJ Case Rep; 2019 Sep; 12(9):. PubMed ID: 31519721
[TBL] [Abstract][Full Text] [Related]
13. Effect of Genetic and Laboratory Findings on Clinical Course of Antisynthetase Syndrome in a Hungarian Cohort.
Szabó K; Bodoki L; Nagy-Vincze M; Vincze A; Zilahi E; Szodoray P; Dankó K; Griger Z
Biomed Res Int; 2018; 2018():6416378. PubMed ID: 30498759
[TBL] [Abstract][Full Text] [Related]
14. Clinical and pathologic differences in interstitial lung disease based on antisynthetase antibody type.
Johnson C; Connors GR; Oaks J; Han S; Truong A; Richardson B; Lechtzin N; Mammen AL; Casciola-Rosen L; Christopher-Stine L; Danoff SK
Respir Med; 2014 Oct; 108(10):1542-8. PubMed ID: 25269710
[TBL] [Abstract][Full Text] [Related]
15. Clinical profile of anti-PL-12 autoantibody. Cohort study and review of the literature.
Kalluri M; Sahn SA; Oddis CV; Gharib SL; Christopher-Stine L; Danoff SK; Casciola-Rosen L; Hong G; Dellaripa PF; Highland KB
Chest; 2009 Jun; 135(6):1550-1556. PubMed ID: 19225060
[TBL] [Abstract][Full Text] [Related]
16. Clinical features of anti-synthetase syndrome associated interstitial lung disease: a retrospective cohort in China.
Zhan X; Yan W; Wang Y; Li Q; Shi X; Gao Y; Ye Q
BMC Pulm Med; 2021 Feb; 21(1):57. PubMed ID: 33579248
[TBL] [Abstract][Full Text] [Related]
17. [Antisynthetase syndrome. Three cases and a review of the literature].
Imbert-Masseau A; Hamidou M; Agard C; Halloun A; Delangle MH; Audrain M; Grolleau JY; Mussini JM
Ann Med Interne (Paris); 2003 Nov; 154(7):483-8. PubMed ID: 14732841
[TBL] [Abstract][Full Text] [Related]
18. [Antisynthetase syndrome: a report of four cases and literature review].
Frikha F; Saidi N; Snoussi M; Ben Salah R; Ben Ayed M; Daoud E; Hentati Y; Makni S; Mnif Z; Boudawara T; Masmoudi H; Bahloul Z
Rev Pneumol Clin; 2012 Dec; 68(6):351-60. PubMed ID: 23062471
[TBL] [Abstract][Full Text] [Related]
19. Clinical heterogeneity and prognostic features of South Australian patients with anti-synthetase autoantibodies.
Dugar M; Cox S; Limaye V; Blumbergs P; Roberts-Thomson PJ
Intern Med J; 2011 Sep; 41(9):674-9. PubMed ID: 20059602
[TBL] [Abstract][Full Text] [Related]
20. Clinical features and outcomes of interstitial lung disease in anti-Jo-1 positive antisynthetase syndrome.
Zamora AC; Hoskote SS; Abascal-Bolado B; White D; Cox CW; Ryu JH; Moua T
Respir Med; 2016 Sep; 118():39-45. PubMed ID: 27578469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
